Erythropoietin: Repair of the Failing Heart* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 185-186

  van der Meer, Peter ^a   Lipsic, Erik ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANGIOGENESIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART PROTECTION; HEMATOCRIT; HUMAN; HYPERTENSION; PLEIOTROPY; PRIORITY JOURNAL; SEIZURE; THROMBOSIS;

ANIMALS; ERYTHROPOIETIN; HEART FAILURE, CONGESTIVE; HEMATOCRIT; HUMANS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 33745282641     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.007     Document Type: Editorial

References (20)

1. Kannel W.B. Incidence and epidemiology of heart failure. Heart Fail Rev 5 (2000) 167-173
2. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
3. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart. the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
4. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
5. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
6. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
7. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
8. van der Meer P., Lipsic E., Henning R.H., et al. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 6 (2004) 853-859
9. Lipsic E., van der Meer P., Henning R.H., et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 44 (2004) 473-479
10. Parsa C.J., Matsumoto A., Kim J., et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112 (2003) 999-1007
11. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
12. Bahlmann F.H., De Groot K., Spandau J.M., et al. Erythropoietin regulates endothelial progenitor cells. Blood 103 (2004) 921-926
13. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
14. van der Meer P., Lipsic E., Henning R.H., et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46 (2005) 125-133
15. Hirata A., Minamino T., Asanuma H., et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 48 (2006) 176-184
16. Bahlmann F.H., Song R., Boehm S.M., et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110 (2004) 1006-1012
17. Fiordaliso F., Chimenti S., Staszewsky L., et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA 102 (2005) 2046-2051
18. Leist M., Ghezzi P., Grasso G., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
19. Ehrenreich H., Hasselblatt M., Dembowski C., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
20. Lipsic E., van der Meer P., Voors A.A., et al. A single bolus of long-acting erythropoietin analogue darbepoetin in patients with an acute myocardial infarction. randomized feasibility and safety study. (abstr). Circulation 112 (2005) II423